tiprankstipranks
Mangoceuticals, Inc. (MGRX)
NASDAQ:MGRX
US Market

Mangoceuticals, Inc. (MGRX) Financial Statements

32 Followers

Mangoceuticals, Inc. Financial Overview

Mangoceuticals, Inc.'s market cap is currently ―. The company's EPS TTM is $-0.597; its P/E ratio is -0.37; Mangoceuticals, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 245.20K$ 141.24K$ 100.72K$ 8.94K-
Gross Profit$ 192.97K$ 87.13K$ 57.20K--
EBIT$ -1.80M$ -2.28M$ -2.56M$ -671.86K-
EBITDA$ -1.79M$ -2.28M$ -2.55M$ -671.86K-
Net Income Common Stockholders$ -1.80M$ -2.28M$ 2.76M$ -673.65K-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.24M$ 2.95M$ 3.81M$ 682.86K$ 873.49K
Total Assets$ 1.60M$ 3.30M$ 4.12M$ 1.00M$ 913.74K
Total Debt$ 143.43K$ 157.54K$ 171.69K$ 352.87K$ 89.20K
Net Debt$ -1.09M$ -2.79M$ -3.64M$ -330.00K$ -784.29K
Total Liabilities$ 240.68K$ 293.87K$ 296.11K$ 389.26K$ 89.87K
Stockholders Equity$ 1.35M$ 3.00M$ 3.82M$ 614.03K$ 823.87K
Cash Flow-
Free Cash Flow$ -1.71M$ -1.78M$ -1.81M$ -690.13K-
Operating Cash Flow$ -1.71M$ -1.78M$ -1.81M$ -649.56K-
Investing Cash Flow--$ -3.52K$ -40.57K-
Financing Cash Flow-$ 935.30K$ 4.92M$ 499.50K-
Currency in USD

Mangoceuticals, Inc. Earnings and Revenue History

Mangoceuticals, Inc. Debt to Assets

Mangoceuticals, Inc. Cash Flow

Mangoceuticals, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis